{"id":"NCT02884206","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction","officialTitle":"A Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-11-23","primaryCompletion":"2022-05-16","completion":"2022-05-16","firstPosted":"2016-08-30","resultsPosted":"2024-08-06","lastUpdate":"2024-08-06"},"enrollment":592,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Heart Failure (CHF)"],"interventions":[{"type":"DRUG","name":"LCZ696","otherNames":[]},{"type":"DRUG","name":"Valsartan","otherNames":[]},{"type":"DRUG","name":"Placebo of LCZ696","otherNames":[]},{"type":"DRUG","name":"Placebo of Valsartan","otherNames":[]}],"arms":[{"label":"LCZ696 200 mg bid","type":"EXPERIMENTAL"},{"label":"Valsartan 160 mg bid","type":"ACTIVE_COMPARATOR"}],"summary":"This study was a multi-center, randomized, double-blind, parallel group, active comparator trial designed to evaluate the overall effect of LCZ696 compared to valsartan on cognitive function as assessed by the CogState comprehensive cognitive battery in patients with Heart failure and preserved ejection fraction (HFpEF).","primaryOutcome":{"measure":"Change From Baseline in the CogState Global Cognitive Composite Score (GCCS)","timeFrame":"Baseline, month 36","effectByArm":[{"arm":"LCZ696 200 mg Bid","deltaMin":-0.0902,"sd":0.0372},{"arm":"Valsartan 160 mg Bid","deltaMin":-0.0722,"sd":0.0383}],"pValues":[{"comp":"OG000 vs OG001","p":"0.7363"}]},"eligibility":{"minAge":"60 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":11},"locations":{"siteCount":135,"countries":["United States","Argentina","Australia","Belgium","Bulgaria","Canada","Croatia","France","Germany","Italy","Lithuania","Netherlands","Poland","Russia","South Korea","Spain","Switzerland","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":318},"commonTop":["Hypotension","Hyperkalaemia","Dizziness","Arthralgia","Nasopharyngitis"]}}